Showing results (1881-1890 of 1,941) with videos related to
Sort By:
Pageof 195
Hepatology Communications|November 9, 2020
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data ValidationDaniel Q Huang, Yee Hui Yeo, Eunice Tan, et al.Cancers|July 2, 2021
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma TreatmentHsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2019
A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinomaChun-Ta Liao, Chia-Hsun Hsieh, Wen-Lang Fan, et al.American Journal of Hematology|May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.International Journal of Environmental Research and Public Health|February 10, 2021
Building a Diverse Workforce and Thinkforce to Reduce Health DisparitiesRichard Yanagihara, Marla J Berry, Monica J Carson, et al.American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.Plos One|September 4, 2015
Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary MalignanciesChun-Ta Liao, Kang-Hsing Fan, Chung-Jan Kang, et al.Scientific Reports|February 15, 2023
A randomized trial on the effect of transcutaneous electrical nerve stimulator on glycemic control in patients with type 2 diabetesJin-Ying Lu, Horng-Yih Ou, Chung-Ze Wu, et al.Cancer Medicine|September 17, 2021
Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelinesLi-Yu Lee, Chien-Yu Lin, Nai-Ming Cheng, et al.Journal of Experimental & Clinical Cancer Research : CR|September 22, 2018
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng-Lung Hsu, Kar-Wai Lui, Lang-Ming Chi, et al.Pageof 195